These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 21293053)

  • 1. ID4: a new player in the cancer arena.
    Dell'Orso S; Ganci F; Strano S; Blandino G; Fontemaggi G
    Oncotarget; 2010 May; 1(1):48-58. PubMed ID: 21293053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis.
    Fontemaggi G; Dell'Orso S; Trisciuoglio D; Shay T; Melucci E; Fazi F; Terrenato I; Mottolese M; Muti P; Domany E; Del Bufalo D; Strano S; Blandino G
    Nat Struct Mol Biol; 2009 Oct; 16(10):1086-93. PubMed ID: 19783986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitor of differentiation 4 (ID4): From development to cancer.
    Patel D; Morton DJ; Carey J; Havrda MC; Chaudhary J
    Biochim Biophys Acta; 2015 Jan; 1855(1):92-103. PubMed ID: 25512197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Id4 promotes senescence and sensitivity to doxorubicin-induced apoptosis in DU145 prostate cancer cells.
    Carey JP; Knowell AE; Chinaranagari S; Chaudhary J
    Anticancer Res; 2013 Oct; 33(10):4271-8. PubMed ID: 24122992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitor of differentiation 4 (ID4) acts as an inhibitor of ID-1, -2 and -3 and promotes basic helix loop helix (bHLH) E47 DNA binding and transcriptional activity.
    Sharma P; Chinaranagari S; Chaudhary J
    Biochimie; 2015 May; 112():139-50. PubMed ID: 25778840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Id4 dependent acetylation restores mutant-p53 transcriptional activity.
    Knowell AE; Patel D; Morton DJ; Sharma P; Glymph S; Chaudhary J
    Mol Cancer; 2013 Dec; 12():161. PubMed ID: 24330748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased ID4 expression, accompanied by mutant p53 accumulation and loss of BRCA1/2 proteins in triple-negative breast cancer, adversely affects survival.
    Thike AA; Tan PH; Ikeda M; Iqbal J
    Histopathology; 2016 Apr; 68(5):702-12. PubMed ID: 26259780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer.
    Carey JP; Asirvatham AJ; Galm O; Ghogomu TA; Chaudhary J
    BMC Cancer; 2009 Jun; 9():173. PubMed ID: 19500415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal regulation and differential actions of the helix-loop-helix transcriptional inhibitors of differentiation (Id1, Id2, Id3, and Id4) in Sertoli cells.
    Chaudhary J; Johnson J; Kim G; Skinner MK
    Endocrinology; 2001 May; 142(5):1727-36. PubMed ID: 11316735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic inactivation of inhibitor of differentiation 4 (Id4) correlates with prostate cancer.
    Sharma P; Chinaranagari S; Patel D; Carey J; Chaudhary J
    Cancer Med; 2012 Oct; 1(2):176-86. PubMed ID: 23342267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
    de Candia P; Akram M; Benezra R; Brogi E
    Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mutant p53-ID4 complex controls VEGFA isoforms by recruiting lncRNA MALAT1.
    Pruszko M; Milano E; Forcato M; Donzelli S; Ganci F; Di Agostino S; De Panfilis S; Fazi F; Bates DO; Bicciato S; Zylicz M; Zylicz A; Blandino G; Fontemaggi G
    EMBO Rep; 2017 Aug; 18(8):1331-1351. PubMed ID: 28652379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of ID4 and its association with TP53 mutation, SOX2, SOX4 and OCT-4 expression levels.
    Galatro TF; Uno M; Oba-Shinjo SM; Almeida AN; Teixeira MJ; Rosemberg S; Marie SK
    PLoS One; 2013; 8(4):e61605. PubMed ID: 23613880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-redundant inhibitor of differentiation (Id) gene expression and function in human prostate epithelial cells.
    Asirvatham AJ; Schmidt MA; Chaudhary J
    Prostate; 2006 Jun; 66(9):921-35. PubMed ID: 16541417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ID4 regulates transcriptional activity of wild type and mutant p53 via K373 acetylation.
    Morton DJ; Patel D; Joshi J; Hunt A; Knowell AE; Chaudhary J
    Oncotarget; 2017 Jan; 8(2):2536-2549. PubMed ID: 27911860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic regulation of ID4 in breast cancer: tumor suppressor or oncogene?
    Nasif D; Campoy E; Laurito S; Branham R; Urrutia G; Roqué M; Branham MT
    Clin Epigenetics; 2018 Aug; 10(1):111. PubMed ID: 30139383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and characterization of Xenopus Id4 reveals differing roles for Id genes.
    Liu KJ; Harland RM
    Dev Biol; 2003 Dec; 264(2):339-51. PubMed ID: 14651922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancer.
    Baker LA; Holliday H; Roden D; Krisp C; Wu SZ; Junankar S; Serandour AA; Mohammed H; Nair R; Sankaranarayanan G; Law AMK; McFarland A; Simpson PT; Lakhani S; Dodson E; Selinger C; Anderson L; Samimi G; Hacker NF; Lim E; Ormandy CJ; Naylor MJ; Simpson K; Nikolic I; O'Toole S; Kaplan W; Cowley MJ; Carroll JS; Molloy M; Swarbrick A
    Breast Cancer Res; 2020 Jun; 22(1):63. PubMed ID: 32527287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitor of differentiation 4 (ID4) inactivation promotes de novo steroidogenesis and castration-resistant prostate cancer.
    Patel D; Knowell AE; Korang-Yeboah M; Sharma P; Joshi J; Glymph S; Chinaranagari S; Nagappan P; Palaniappan R; Bowen NJ; Chaudhary J
    Mol Endocrinol; 2014 Aug; 28(8):1239-53. PubMed ID: 24921661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of ID4 protein in breast cancer cells induces reprogramming of tumour-associated macrophages.
    Donzelli S; Milano E; Pruszko M; Sacconi A; Masciarelli S; Iosue I; Melucci E; Gallo E; Terrenato I; Mottolese M; Zylicz M; Zylicz A; Fazi F; Blandino G; Fontemaggi G
    Breast Cancer Res; 2018 Jun; 20(1):59. PubMed ID: 29921315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.